{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:12:01Z","timestamp":1792721521340,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s11060-020-03553-1","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T11:03:43Z","timestamp":1597662223000},"page":"27-34","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Diffuse midline glioma: review of epigenetics"],"prefix":"10.1007","volume":"150","author":[{"given":"Tabitha M.","family":"Cooney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Lubanszky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachna","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3452-5150","authenticated-orcid":false,"given":"Sabine","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"issue":"5","key":"3553_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS (2019) CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012\u20132016. Neuro Oncol 21(5):v1\u2013v100. https:\/\/doi.org\/10.1093\/neuonc\/noz150","journal-title":"Neuro Oncol"},{"issue":"9","key":"3553_CR2","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/neuonc\/nox107","volume":"19","author":"T Cooney","year":"2017","unstructured":"Cooney T, Lane A, Bartels U, Bouffet E, Goldman S, Leary SES, Foreman NK, Packer RJ, Broniscer A, Minturn JE, Shih CS, Chintagumpala M, Hassall T, Gottardo NG, Dholaria H, Hoffman L, Chaney B, Baugh J, Doughman R, Leach JL, Jones BV, Fouladi M, Warren KE, Monje M (2017) Contemporary survival endpoints: an international diffuse intrinsic pontine glioma registry study. Neuro Oncol 19(9):1279\u20131280. https:\/\/doi.org\/10.1093\/neuonc\/nox107","journal-title":"Neuro Oncol"},{"issue":"3","key":"3553_CR3","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","volume":"124","author":"DA Khuong-Quang","year":"2012","unstructured":"Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM, Bouffet E, Bartels U, Albrecht S, Schwartzentruber J, Letourneau L, Bourgey M, Bourque G, Montpetit A, Bourret G, Lepage P, Fleming A, Lichter P, Kool M, von Deimling A, Sturm D, Korshunov A, Faury D, Jones DT, Majewski J, Pfister SM, Jabado N, Hawkins C (2012) K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124(3):439\u2013447. https:\/\/doi.org\/10.1007\/s00401-012-0998-0","journal-title":"Acta Neuropathol"},{"issue":"5","key":"3553_CR4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1586\/14789450.2.5.719","volume":"2","author":"L Marino-Ramirez","year":"2005","unstructured":"Marino-Ramirez L, Kann MG, Shoemaker BA, Landsman D (2005) Histone structure and nucleosome stability. Expert Rev Proteomics 2(5):719\u2013729. https:\/\/doi.org\/10.1586\/14789450.2.5.719","journal-title":"Expert Rev Proteomics"},{"issue":"2","key":"3553_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0006-291x(90)92368-a","volume":"168","author":"MF Hacques","year":"1990","unstructured":"Hacques MF, Muller S, De Murcia G, Van Regenmortel MH, Marion C (1990) Use of an immobilized enzyme and specific antibodies to analyse the accessibility and role of histone tails in chromatin structure. Biochem Biophys Res Commun 168(2):637\u2013643. https:\/\/doi.org\/10.1016\/0006-291x(90)92368-a","journal-title":"Biochem Biophys Res Commun"},{"key":"3553_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1146\/annurev.genet.032608.103928","volume":"43","author":"EI Campos","year":"2009","unstructured":"Campos EI, Reinberg D (2009) Histones: annotating chromatin. Annu Rev Genet 43:559\u2013599. https:\/\/doi.org\/10.1146\/annurev.genet.032608.103928","journal-title":"Annu Rev Genet"},{"issue":"11","key":"3553_CR7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nrg3554","volume":"14","author":"C Plass","year":"2013","unstructured":"Plass C, Pfister SM, Lindroth AM, Bogatyrova O, Claus R, Lichter P (2013) Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nat Rev Genet 14(11):765\u2013780. https:\/\/doi.org\/10.1038\/nrg3554","journal-title":"Nat Rev Genet"},{"issue":"12","key":"3553_CR8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nrc.2016.83","volume":"16","author":"I Comet","year":"2016","unstructured":"Comet I, Riising EM, Leblanc B, Helin K (2016) Maintaining cell identity: PRC2-mediated regulation of transcription and cancer. Nat Rev Cancer 16(12):803\u2013810. https:\/\/doi.org\/10.1038\/nrc.2016.83","journal-title":"Nat Rev Cancer"},{"issue":"7384","key":"3553_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tonjes M, Hovestadt V, Albrecht S, Kool M, Nantel A, Konermann C, Lindroth A, Jager N, Rausch T, Ryzhova M, Korbel JO, Hielscher T, Hauser P, Garami M, Klekner A, Bognar L, Ebinger M, Schuhmann MU, Scheurlen W, Pekrun A, Fruhwald MC, Roggendorf W, Kramm C, Durken M, Atkinson J, Lepage P, Montpetit A, Zakrzewska M, Zakrzewski K, Liberski PP, Dong Z, Siegel P, Kulozik AE, Zapatka M, Guha A, Malkin D, Felsberg J, Reifenberger G, von Deimling A, Ichimura K, Collins VP, Witt H, Milde T, Witt O, Zhang C, Castelo-Branco P, Lichter P, Faury D, Tabori U, Plass C, Majewski J, Pfister SM, Jabado N (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482(7384):226\u2013231. https:\/\/doi.org\/10.1038\/nature10833","journal-title":"Nature"},{"issue":"6134","key":"3553_CR10","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1126\/science.1232245","volume":"340","author":"PW Lewis","year":"2013","unstructured":"Lewis PW, Muller MM, Koletsky MS, Cordero F, Lin S, Banaszynski LA, Garcia BA, Muir TW, Becher OJ, Allis CD (2013) Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340(6134):857\u2013861. https:\/\/doi.org\/10.1126\/science.1232245","journal-title":"Science"},{"issue":"2","key":"3553_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/neuonc\/now101","volume":"19","author":"C Jones","year":"2017","unstructured":"Jones C, Karajannis MA, Jones DTW, Kieran MW, Monje M, Baker SJ, Becher OJ, Cho YJ, Gupta N, Hawkins C, Hargrave D, Haas-Kogan DA, Jabado N, Li XN, Mueller S, Nicolaides T, Packer RJ, Persson AI, Phillips JJ, Simonds EF, Stafford JM, Tang Y, Pfister SM, Weiss WA (2017) Pediatric high-grade glioma: biologically and clinically in need of new thinking. Neuro Oncol 19(2):153\u2013161. https:\/\/doi.org\/10.1093\/neuonc\/now101","journal-title":"Neuro Oncol"},{"issue":"6","key":"3553_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131(6):803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"issue":"5","key":"3553_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/ng.2936","volume":"46","author":"P Buczkowicz","year":"2014","unstructured":"Buczkowicz P, Hoeman C, Rakopoulos P, Pajovic S, Letourneau L, Dzamba M, Morrison A, Lewis P, Bouffet E, Bartels U, Zuccaro J, Agnihotri S, Ryall S, Barszczyk M, Chornenkyy Y, Bourgey M, Bourque G, Montpetit A, Cordero F, Castelo-Branco P, Mangerel J, Tabori U, Ho KC, Huang A, Taylor KR, Mackay A, Bendel AE, Nazarian J, Fangusaro JR, Karajannis MA, Zagzag D, Foreman NK, Donson A, Hegert JV, Smith A, Chan J, Lafay-Cousin L, Dunn S, Hukin J, Dunham C, Scheinemann K, Michaud J, Zelcer S, Ramsay D, Cain J, Brennan C, Souweidane MM, Jones C, Allis CD, Brudno M, Becher O, Hawkins C (2014) Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet 46(5):451\u2013456. https:\/\/doi.org\/10.1038\/ng.2936","journal-title":"Nat Genet"},{"issue":"1","key":"3553_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ccell.2018.11.015","volume":"35","author":"JD Larson","year":"2019","unstructured":"Larson JD, Kasper LH, Paugh BS, Jin H, Wu G, Kwon CH, Fan Y, Shaw TI, Silveira AB, Qu C, Xu R, Zhu X, Zhang J, Russell HR, Peters JL, Finkelstein D, Xu B, Lin T, Tinkle CL, Patay Z, Onar-Thomas A, Pounds SB, McKinnon PJ, Ellison DW, Zhang J, Baker SJ (2019) Histone H3.3 K27M Accelerates Spontaneous Brainstem Glioma and Drives Restricted Changes in Bivalent Gene Expression. Cancer Cell 35(1):140\u2013155. https:\/\/doi.org\/10.1016\/j.ccell.2018.11.015","journal-title":"Cancer Cell"},{"issue":"9","key":"3553_CR15","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1158\/1541-7786.MCR-16-0389","volume":"15","author":"FJ Cordero","year":"2017","unstructured":"Cordero FJ, Huang Z, Grenier C, He X, Hu G, McLendon RE, Murphy SK, Hashizume R, Becher OJ (2017) Histone H33K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG. Mol Cancer Res 15(9):1243\u20131254. https:\/\/doi.org\/10.1158\/1541-7786.MCR-16-0389","journal-title":"Mol Cancer Res"},{"issue":"5","key":"3553_CR16","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ccell.2017.09.014","volume":"32","author":"M Pathania","year":"2017","unstructured":"Pathania M, De Jay N, Maestro N, Harutyunyan AS, Nitarska J, Pahlavan P, Henderson S, Mikael LG, Richard-Londt A, Zhang Y, Costa JR, Hebert S, Khazaei S, Ibrahim NS, Herrero J, Riccio A, Albrecht S, Ketteler R, Brandner S, Kleinman CL, Jabado N, Salomoni P (2017) H3.3(K27M) Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas. Cancer Cell 32(5):684\u2013700. https:\/\/doi.org\/10.1016\/j.ccell.2017.09.014","journal-title":"Cancer Cell"},{"issue":"5","key":"3553_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","volume":"24","author":"S Bender","year":"2013","unstructured":"Bender S, Tang Y, Lindroth AM, Hovestadt V, Jones DT, Kool M, Zapatka M, Northcott PA, Sturm D, Wang W, Radlwimmer B, Hojfeldt JW, Truffaux N, Castel D, Schubert S, Ryzhova M, Seker-Cin H, Gronych J, Johann PD, Stark S, Meyer J, Milde T, Schuhmann M, Ebinger M, Monoranu CM, Ponnuswami A, Chen S, Jones C, Witt O, Collins VP, von Deimling A, Jabado N, Puget S, Grill J, Helin K, Korshunov A, Lichter P, Monje M, Plass C, Cho YJ, Pfister SM (2013) Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell 24(5):660\u2013672. https:\/\/doi.org\/10.1016\/j.ccr.2013.10.006","journal-title":"Cancer Cell"},{"key":"3553_CR18","doi-asserted-by":"publisher","first-page":"11316","DOI":"10.1038\/ncomms11316","volume":"7","author":"N Justin","year":"2016","unstructured":"Justin N, Zhang Y, Tarricone C, Martin SR, Chen S, Underwood E, De Marco V, Haire LF, Walker PA, Reinberg D, Wilson JR, Gamblin SJ (2016) Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2. Nat Commun 7:11316. https:\/\/doi.org\/10.1038\/ncomms11316","journal-title":"Nat Commun"},{"issue":"44","key":"3553_CR19","doi-asserted-by":"publisher","first-page":"22152","DOI":"10.1073\/pnas.1911775116","volume":"116","author":"KL Diehl","year":"2019","unstructured":"Diehl KL, Ge EJ, Weinberg DN, Jani KS, Allis CD, Muir TW (2019) PRC2 engages a bivalent H3K27M-H3K27me3 dinucleosome inhibitor. Proc Natl Acad Sci U S A 116(44):22152\u201322157. https:\/\/doi.org\/10.1073\/pnas.1911775116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3553_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nm.4296","volume":"23","author":"A Piunti","year":"2017","unstructured":"Piunti A, Hashizume R, Morgan MA, Bartom ET, Horbinski CM, Marshall SA, Rendleman EJ, Ma Q, Takahashi YH, Woodfin AR, Misharin AV, Abshiru NA, Lulla RR, Saratsis AM, Kelleher NL, James CD, Shilatifard A (2017) Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas. Nat Med 23(4):493\u2013500. https:\/\/doi.org\/10.1038\/nm.4296","journal-title":"Nat Med"},{"issue":"6200","key":"3553_CR21","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1126\/science.1255104","volume":"345","author":"HM Herz","year":"2014","unstructured":"Herz HM, Morgan M, Gao X, Jackson J, Rickels R, Swanson SK, Florens L, Washburn MP, Eissenberg JC, Shilatifard A (2014) Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling. Science 345(6200):1065\u20131070. https:\/\/doi.org\/10.1126\/science.1255104","journal-title":"Science"},{"issue":"5","key":"3553_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1101\/gad.415507","volume":"21","author":"AP Bracken","year":"2007","unstructured":"Bracken AP, Kleine-Kohlbrecher D, Dietrich N, Pasini D, Gargiulo G, Beekman C, Theilgaard-Monch K, Minucci S, Porse BT, Marine JC, Hansen KH, Helin K (2007) The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 21(5):525\u2013530. https:\/\/doi.org\/10.1101\/gad.415507","journal-title":"Genes Dev"},{"key":"3553_CR23","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1038\/ncomms4649","volume":"5","author":"A Piunti","year":"2014","unstructured":"Piunti A, Rossi A, Cerutti A, Albert M, Jammula S, Scelfo A, Cedrone L, Fragola G, Olsson L, Koseki H, Testa G, Casola S, Helin K, d'Adda di Fagagna F, Pasini D (2014) Polycomb proteins control proliferation and transformation independently of cell cycle checkpoints by regulating DNA replication. Nat Commun 5:3649. https:\/\/doi.org\/10.1038\/ncomms4649","journal-title":"Nat Commun"},{"issue":"10","key":"3553_CR24","doi-asserted-by":"publisher","first-page":"eaau5935","DOI":"10.1126\/sciadv.aau5935","volume":"4","author":"JM Stafford","year":"2018","unstructured":"Stafford JM, Lee CH, Voigt P, Descostes N, Saldana-Meyer R, Yu JR, Leroy G, Oksuz O, Chapman JR, Suarez F, Modrek AS, Bayin NS, Placantonakis DG, Karajannis MA, Snuderl M, Ueberheide B, Reinberg D (2018) Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric glioma. Sci Adv 4(10):eaau5935. https:\/\/doi.org\/10.1126\/sciadv.aau5935","journal-title":"Sci Adv"},{"issue":"5","key":"3553_CR25","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.cell.2010.01.003","volume":"140","author":"AD Goldberg","year":"2010","unstructured":"Goldberg AD, Banaszynski LA, Noh KM, Lewis PW, Elsaesser SJ, Stadler S, Dewell S, Law M, Guo X, Li X, Wen D, Chapgier A, DeKelver RC, Miller JC, Lee YL, Boydston EA, Holmes MC, Gregory PD, Greally JM, Rafii S, Yang C, Scambler PJ, Garrick D, Gibbons RJ, Higgs DR, Cristea IM, Urnov FD, Zheng D, Allis CD (2010) Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140(5):678\u2013691. https:\/\/doi.org\/10.1016\/j.cell.2010.01.003","journal-title":"Cell"},{"issue":"4","key":"3553_CR26","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","volume":"32","author":"A Mackay","year":"2017","unstructured":"Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR, Bjerke L, Clarke M, Vinci M, Nandhabalan M, Temelso S, Popov S, Molinari V, Raman P, Waanders AJ, Han HJ, Gupta S, Marshall L, Zacharoulis S, Vaidya S, Mandeville HC, Bridges LR, Martin AJ, Al-Sarraj S, Chandler C, Ng HK, Li X, Mu K, Trabelsi S, Brahim DH, Kisljakov AN, Konovalov DM, Moore AS, Carcaboso AM, Sunol M, de Torres C, Cruz O, Mora J, Shats LI, Stavale JN, Bidinotto LT, Reis RM, Entz-Werle N, Farrell M, Cryan J, Crimmins D, Caird J, Pears J, Monje M, Debily MA, Castel D, Grill J, Hawkins C, Nikbakht H, Jabado N, Baker SJ, Pfister SM, Jones DTW, Fouladi M, von Bueren AO, Baudis M, Resnick A, Jones C (2017) Integrated Molecular Meta-Analysis of 1000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma. Cancer Cell 32(4):520\u2013553. https:\/\/doi.org\/10.1016\/j.ccell.2017.08.017","journal-title":"Cancer Cell"},{"issue":"5","key":"3553_CR27","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.cell.2017.07.016","volume":"170","author":"EY Qin","year":"2017","unstructured":"Qin EY, Cooper DD, Abbott KL, Lennon J, Nagaraja S, Mackay A, Jones C, Vogel H, Jackson PK, Monje M (2017) Neural Precursor-Derived Pleiotrophin Mediates Subventricular Zone Invasion by Glioma. Cell 170(5):845\u2013859. https:\/\/doi.org\/10.1016\/j.cell.2017.07.016","journal-title":"Cell"},{"issue":"6","key":"3553_CR28","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00401-015-1478-0","volume":"130","author":"D Castel","year":"2015","unstructured":"Castel D, Philippe C, Calmon R, Le Dret L, Truffaux N, Boddaert N, Pages M, Taylor KR, Saulnier P, Lacroix L, Mackay A, Jones C, Sainte-Rose C, Blauwblomme T, Andreiuolo F, Puget S, Grill J, Varlet P, Debily MA (2015) Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 130(6):815\u2013827. https:\/\/doi.org\/10.1007\/s00401-015-1478-0","journal-title":"Acta Neuropathol"},{"issue":"6","key":"3553_CR29","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.molcel.2019.08.030","volume":"76","author":"S Nagaraja","year":"2019","unstructured":"Nagaraja S, Quezada MA, Gillespie SM, Arzt M, Lennon JJ, Woo PJ, Hovestadt V, Kambhampati M, Filbin MG, Suva ML, Nazarian J, Monje M (2019) Histone Variant and Cell Context Determine H3K27M Reprogramming of the Enhancer Landscape and Oncogenic State. Mol Cell 76(6):965\u2013980. https:\/\/doi.org\/10.1016\/j.molcel.2019.08.030","journal-title":"Mol Cell"},{"issue":"7","key":"3553_CR30","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nm0715-827a","volume":"21","author":"CS Grasso","year":"2015","unstructured":"Grasso CS, Tang Y, Truffaux N, Berlow NE, Liu L, Debily MA, Quist MJ, Davis LE, Huang EC, Woo PJ, Ponnuswami A, Chen S, Johung TB, Sun W, Kogiso M, Du Y, Qi L, Huang Y, Hutt-Cabezas M, Warren KE, Le Dret L, Meltzer PS, Mao H, Quezado M, van Vuurden DG, Abraham J, Fouladi M, Svalina MN, Wang N, Hawkins C, Nazarian J, Alonso MM, Raabe EH, Hulleman E, Spellman PT, Li XN, Keller C, Pal R, Grill J, Monje M (2015) Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med 21(7):827. https:\/\/doi.org\/10.1038\/nm0715-827a","journal-title":"Nat Med"},{"key":"3553_CR31","doi-asserted-by":"publisher","first-page":"i53","DOI":"10.1093\/neuonc\/noy059.115","volume":"20","author":"T Cooney","year":"2018","unstructured":"Cooney T, Onar-Thomas A, Huang J, Lulla R, Fangusaro J, Kramer K, Baxter P, Fouladi M, Dunkel IJ, Warren KE, Monje M (2018) DIPG-22 A Phase 1 Trial Of The Histone Deacetylase Inhibitor Panobinostat In Pediatric Patients With Recurrent Or Refractory Diffuse Intrinsic Pontine Glioma: A Pediatric Brain Tumor Consortium (Pbtc) Study. Neuro Oncol 20:i53. https:\/\/doi.org\/10.1093\/neuonc\/noy059.115","journal-title":"Neuro Oncol"},{"issue":"7","key":"3553_CR32","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1002\/ijc.32258","volume":"145","author":"S Mueller","year":"2019","unstructured":"Mueller S, Jain P, Liang WS, Kilburn L, Kline C, Gupta N, Panditharatna E, Magge SN, Zhang B, Zhu Y, Crawford JR, Banerjee A, Nazemi K, Packer RJ, Petritsch CK, Truffaux N, Roos A, Nasser S, Phillips JJ, Solomon D, Molinaro A, Waanders AJ, Byron SA, Berens ME, Kuhn J, Nazarian J, Prados M, Resnick AC (2019) A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: A report from the Pacific Pediatric Neuro-Oncology Consortium. Int J Cancer 145(7):1889\u20131901. https:\/\/doi.org\/10.1002\/ijc.32258","journal-title":"Int J Cancer"},{"key":"3553_CR33","doi-asserted-by":"publisher","first-page":"i64","DOI":"10.1093\/neuonc\/noy059.168","volume":"20","author":"L Kilburn","year":"2018","unstructured":"Kilburn L, Kuhn J, Nazemi K, Molinaro A, Liang W, Banerjee A, Hwang E, Crawford J, Nicolaides T, Packer R, Nazarian J, Gupta N, Resnick AC, Byron S, Berens M, Prados M, Mueller S (2018) DIPG-76 PNOC-003: Precision medicine trial for children with diffuses intrinsic pontine glioma: preliminary experience with multi-agent personalized therapy recommendations. Neuro Oncol 20:i64. https:\/\/doi.org\/10.1093\/neuonc\/noy059.168","journal-title":"Neuro Oncol"},{"issue":"6","key":"3553_CR34","doi-asserted-by":"publisher","first-page":"e332","DOI":"10.1097\/MPH.0000000000000806","volume":"39","author":"ZJ Wang","year":"2017","unstructured":"Wang ZJ, Ge Y, Altinok D, Poulik J, Sood S, Taub JW, Edwards H, Kieran MW, Steven M (2017) Concomitant Use of Panobinostat and Reirradiation in Progressive DIPG: Report of 2 Cases. J Pediatr Hematol Oncol 39(6):e332\u2013e335. https:\/\/doi.org\/10.1097\/MPH.0000000000000806","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"3553_CR35","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3171\/2018.2.PEDS17663","volume":"22","author":"WGB Singleton","year":"2018","unstructured":"Singleton WGB, Bienemann AS, Woolley M, Johnson D, Lewis O, Wyatt MJ, Damment SJP, Boulter LJ, Killick-Cole CL, Asby DJ, Gill SS (2018) The distribution, clearance, and brainstem toxicity of panobinostat administered by convection-enhanced delivery. J Neurosurg Pediatr 22(3):288\u2013296. https:\/\/doi.org\/10.3171\/2018.2.PEDS17663","journal-title":"J Neurosurg Pediatr"},{"issue":"38","key":"3553_CR36","doi-asserted-by":"publisher","first-page":"62962","DOI":"10.18632\/oncotarget.18002","volume":"8","author":"SS Kumar","year":"2017","unstructured":"Kumar SS, Sengupta S, Lee K, Hura N, Fuller C, DeWire M, Stevenson CB, Fouladi M, Drissi R (2017) BMI-1 is a potential therapeutic target in diffuse intrinsic pontine glioma. Oncotarget 8(38):62962\u201362975. https:\/\/doi.org\/10.18632\/oncotarget.18002","journal-title":"Oncotarget"},{"key":"3553_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw0064","author":"GL Lin","year":"2019","unstructured":"Lin GL, Wilson KM, Ceribelli M, Stanton BZ, Woo PJ, Kreimer S, Qin EY, Zhang X, Lennon J, Nagaraja S, Morris PJ, Quezada M, Gillespie SM, Duveau DY, Michalowski AM, Shinn P, Guha R, Ferrer M, Klumpp-Thomas C, Michael S, McKnight C, Minhas P, Itkin Z, Raabe EH, Chen L, Ghanem R, Geraghty AC, Ni L, Andreasson KI, Vitanza NA, Warren KE, Thomas CJ, Monje M (2019) Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aaw0064","journal-title":"Sci Transl Med"},{"issue":"5","key":"3553_CR38","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ccell.2019.09.005","volume":"36","author":"JN Anastas","year":"2019","unstructured":"Anastas JN, Zee BM, Kalin JH, Kim M, Guo R, Alexandrescu S, Blanco MA, Giera S, Gillespie SM, Das J, Wu M, Nocco S, Bonal DM, Nguyen QD, Suva ML, Bernstein BE, Alani R, Golub TR, Cole PA, Filbin MG, Shi Y (2019) Re-programing Chromatin with a Bifunctional LSD1\/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG. Cancer Cell 36(5):528\u2013544. https:\/\/doi.org\/10.1016\/j.ccell.2019.09.005","journal-title":"Cancer Cell"},{"issue":"4","key":"3553_CR39","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00401-014-1307-x","volume":"128","author":"V Caretti","year":"2014","unstructured":"Caretti V, Bugiani M, Freret M, Schellen P, Jansen M, van Vuurden D, Kaspers G, Fisher PG, Hulleman E, Wesseling P, Vogel H, Monje M (2014) Subventricular spread of diffuse intrinsic pontine glioma. Acta Neuropathol 128(4):605\u2013607. https:\/\/doi.org\/10.1007\/s00401-014-1307-x","journal-title":"Acta Neuropathol"},{"key":"3553_CR40","doi-asserted-by":"crossref","unstructured":"Biery M, Myers, C., Girard, E., Morris, S., Carmack, S., Noll, A., Sarthy, J., Ferguson, E., Mhyre, A., Strand, A., Olson, J., Vitanza, N. (2018) DIPG-35. A novel HDAC inhibitor in new patient-derived diffuse intrinsic pontine glioma (DIPG) model Neuro Oncol 20:i56","DOI":"10.1093\/neuonc\/noy059.128"},{"issue":"5","key":"3553_CR41","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ccell.2017.03.011","volume":"31","author":"S Nagaraja","year":"2017","unstructured":"Nagaraja S, Vitanza NA, Woo PJ, Taylor KR, Liu F, Zhang L, Li M, Meng W, Ponnuswami A, Sun W, Ma J, Hulleman E, Swigut T, Wysocka J, Tang Y, Monje M (2017) Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma. Cancer Cell 31(5):635\u2013652. https:\/\/doi.org\/10.1016\/j.ccell.2017.03.011","journal-title":"Cancer Cell"},{"issue":"11","key":"3553_CR42","doi-asserted-by":"publisher","first-page":"9612","DOI":"10.18632\/oncotarget.3324","volume":"6","author":"AD Orskov","year":"2015","unstructured":"Orskov AD, Treppendahl MB, Skovbo A, Holm MS, Friis LS, Hokland M, Gronbaek K (2015) Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS\/AML patients: A rationale for combined targeting of PD-1 and DNA methylation. Oncotarget 6(11):9612\u20139626. https:\/\/doi.org\/10.18632\/oncotarget.3324","journal-title":"Oncotarget"},{"issue":"47","key":"3553_CR43","doi-asserted-by":"publisher","first-page":"83155","DOI":"10.18632\/oncotarget.17950","volume":"8","author":"L Booth","year":"2017","unstructured":"Booth L, Roberts JL, Poklepovic A, Kirkwood J, Dent P (2017) HDAC inhibitors enhance the immunotherapy response of melanoma cells. Oncotarget 8(47):83155\u201383170. https:\/\/doi.org\/10.18632\/oncotarget.17950","journal-title":"Oncotarget"},{"issue":"6","key":"3553_CR44","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2017.10.022","volume":"171","author":"MJ Topper","year":"2017","unstructured":"Topper MJ, Vaz M, Chiappinelli KB, DeStefano Shields CE, Niknafs N, Yen RC, Wenzel A, Hicks J, Ballew M, Stone M, Tran PT, Zahnow CA, Hellmann MD, Anagnostou V, Strissel PL, Strick R, Velculescu VE, Baylin SB (2017) Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer. Cell 171(6):1284\u20131300. https:\/\/doi.org\/10.1016\/j.cell.2017.10.022","journal-title":"Cell"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03553-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-020-03553-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03553-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T23:31:03Z","timestamp":1629156663000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-020-03553-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["3553"],"URL":"https:\/\/doi.org\/10.1007\/s11060-020-03553-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,17]]},"assertion":[{"value":"17 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no competing interests or conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}